PRTN3 and rheumatoid arthritis: While Tfh cell frequency was comparable between ACPA+ and ACPA− RA (Figure 3A,B), naïve to treatment ACPA− RA patients had significantly (** p = 0.006) higher frequency of Tfh cells compared to patients undergoing treatment (Figure 3D).